Publicidad
Artículo original 10 de setiembre de 2015

Atividades de radioisótopos administradas em medicina nuclear e proposta de nível de referência em diagnóstico (DRL) para pacientes adultos e pediátricos no Brasil

Referenciar Imprimir Descargar PDF

Referencias

  1. Brenner DJ, Hall EJ. Computed tomography – an increasing source of radiation exposure. N Engl J Med 2007; 357:2277-84.
  2. Hayward C. Fusion imaging is growing fast. SpaceMed Newsletter; 2010. Acessado em Vol. 3, nº2, 2010. [http://www.spacemed.com/newsletter/trend-32-fusionimaging.pdf]. Acessado em 22 maio 2015.
  3. Fahey FH, Treves ST, Adelstein SJ. Minimizing and communicating radiation risk in pediatric nuclear medicine. J Nucl Med. 2011;52:1240-51.
  4. International Commission on Radiological Protection. Recommendations of the International Commission on Radiological Protection. ICRP Publication 60 (Oxford: Pergamon Press) (1991).
  5. Edmonds KD. Diagnostic reference levels as a quality assurance tool. Radiographer 2009;56:32-37.
  6. Wall BF. Diagnostic reference levels – the way forward. BJR 2001;74:785-8.
  7. International Atomic Energy Agency. International Basic Safety Standards for protection against ionizing radiation and for the safety of radiation sources. Basic Safety Series No. 115. Vienna: International Atomic Energy Agency;1996.
  8. European Commission. Guidance on diagnostic reference levels (DRLs) for medical exposures. Radiation Protection 109, 1999.
  9. Gelfand MJ, Parisi MT, Treves ST. Pediatric nuclear medicine dose reduction workgroup. Pediatric radiopharmaceutical administered doses: 2010 North American consensus guidelines. J Nucl Med 2011;52:318-22.
  10. Lassmann M, Biassoni L, Monsieurs M, et al. EANM Dosimetry and Paediatrics Committees. The new EANM paediatric dosage card. Eur J Nucl Med Mol Imaging 2007;34:796-8.
  11. Lassmann M, Treves ST. EANM/SNMMI Paediatric Dosage harmonization working group. Paediatric radiopharmaceutical administration: harmonization of the 2007 EANM paediatric dosage card (version 1.5.2008) and the 2010 North American consensus guidelines. Eur J Nucl Med Mol Imaging 2014;41:1036-4
  12. Society of Nuclear Medicine and Molecular Imaging - SNMMI. Procedures Standards. Disponível em: [http://www.snmmi.org/Physicians.aspx]. Acessado em 22 maio 2015.
  13. European Association of Nuclear Medicine and Molecular Imaging - EANMMI. Guidelines. Disponível em: [http://www.eanm.org/publications/guidelines/index.php?navId=37]. Acessado em 22 maio 2015.
  14. Araújo AR, Khoury HJ, Lima FF. Dose efetiva coletiva na população pernambucana devido a procedimentos diagnósticos em medicina nuclear. Scientia Plena 2010;(6)-044101:1-7.
  15. Oliveira CM, Sá LV, Alonso TC, et al. Sugestão de nível de referência em diagnóstico nacional para 18F-FDG/PET em procedimentos oncológicos adultos no Brasil. Radiol Bras 2013;46:284-9.
  16. Comissão Nacional de Energia Nuclear. Requisitos de segurança e proteção radiológica para serviços de medicina nuclear. CNEN NN 3.05; 2013.
  17. Blanco S1, Mora P, Almonte N, et al. Determination of diagnostic reference levels in general radiography in Latin America. Radiat Prot Dosimetry 2013;156:303-9.
  18. Reiners C, Lassmann M. Assessment of patient exposure in nuclear medicine. Rad Protec Dosimetry 1998;80:243-248.
  19. International Commission on Radiological Protection. Diagnostic reference levels in medical imaging: review and additional advice. Disponível em [http://www.icrp.org/docs/DRL_for_web.pdf]. Acessado em 21 maio 2015.
  20. Korpela H, Bly R, Vassileva J, et al. Recently revised diagnostic reference levels in nuclear medicine in Bulgaria and in Finland. Radiat Prot Dosimetry 2010;139:317-20.
  21. Vogiatzi S, Kipouros P, Chobis M. Establishment of dose reference levels for nuclear medicine in Greece. Radiat Prot Dosimetry 2011;147:237-9.
  22. Roch P, Aubert B. French diagnostic reference levels in diagnostic radiology, computed tomography and nuclear medicine: 2004-2008 review. Radiat Prot Dosimetry 2013;154:52-75.
  23. European Commission. Diagnostic reference levels in thirty-six European countries – Part 2/2. Radiation Protection No. 180; 2014. Disponível em [http://ec.europa.eu/energy/sites/ener/files/documents/RP180%20part2.pdf]. Acesso maio 2015.
  24. World Health Organization. Global Health Observatory (GHO) data. Overweight and obesity. Disponível em [http://www.who.int/gho/ncd/risk_factors/overweight/en/]. Acessado em 22 maio 2015.
  25. Piepsz A, Hahn K, Roca I, et al. A radiopharmaceuticals schedule for imaging in paediatrics. Paediatric Task Group European Association Nuclear Medicine. Eur J Nucl Med 1990;17:127-9.
  26. Jacobs F, Thierens H, Piepsz A, et al. European Association of Nuclear Medicine. Optimised tracer-dependent dosage cards to obtain weight-independent effective doses. Eur J Nucl Med Mol Imaging 2005;32:581-8.
  27. Holm S, Borgwardt L, Loft A, et al. Paediatric doses--a critical appraisal of the EANM paediatric dosage card. Eur J Nucl Med Mol Imaging 2007;34:1713-8.
  28. Fahey FH, Bom HH, Chiti A, et al. Standardization of administered activities in pediatric nuclear medicine: a report of the first nuclear medicine global initiative project, part 1-statement of the issue and a review of available resources. J Nucl Med 2015;56:646-51.
  29. Mattsson S, Jacobsson L, Vestergren E. The basic principles in assessment and selection of reference doses: consideration in nuclear medicine. Radiat Prot Dosimetry 1998;80:23-27.
  30. McCready R, A'Hern R. A more rational basis for determining the activities used for radionuclide imaging Eur J Nucl Med 1997;24:109-10.